Introduction: Antimicrobial resistance (AMR) is a serious health threat, and it has high priority among the European public health agenda. The development and implementation of the National Action Plans (NAPs) with a One-Health perspective to fight AMR was supported in 2017 by the European Union (EU) through a Joint Action on Antimicrobial Resistance and Healthcare Associated Infections (EU-JAMRAI). The Italian National Institute of Health (Istituto Superiore di Sanità), supported by the University of Udine, and the University of Foggia were among the 44 partners involved. This paper describes the results of EU-JAMRAI relevant to Italy and its impact on national policies. Methods: The activities involved national and international experts who worked in groups, either in virtual or face-to-face meetings. Country-to-country visits were organized to assess and compare the national strategies to counteract AMR and to exchange best practices. In addition, qualitative research methods, particularly focus groups (FGs) and structured interviews, were carried out to collect information and opinions from the experts. Results: The Italian team of experts from the Ministry of Health and the University of Foggia visited the Netherlands and hosted the Polish expert team in Italy. In two FG, stakeholders’ opinions from different organizations were collected and analyzed to identify critical areas and provide recommendations to ensure implementation of the NAP and effective One-Health integration. In addition, attitudes of medical professionals toward antimicrobial stewardship were evaluated in a medium/large Italian hospital. Strengths were identified in the multidisciplinary approach and the hospital management’s proactive involvement. As for the veterinary sector, Italy was among the 10 EU countries that did not have any national AMR surveillance in place for animal bacterial pathogens. Consequently, a European surveillance system was proposed with the adhesion of Italy. Regarding research and innovation to fight AMR and healthcare-associated infection, Italy worked with the other European partners to identify national research gaps and opportunities. As a result, recommendations were issued to the authorities to promote research and innovation with a One-Health approach. Conclusions: The Italian participation in the EU JAMRAI provided experience and examples to the Italian government for implementing the NAP and planning the roadmap to fight AMR and helped point out the system’s criticalities. It also supported the promotion of the One-Health integrated vision that was included in the updated NAP.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.
Antimicrobial Resistance Collaborators; Ikuta KS, Sharara F. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–55.
COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022: National Center for Emerging and Zoonotic Infectious Diseases; 2022.
European Centre for Disease Prevention and Control, World Health Organization. Antimicrobial resistance surveillance in Europe: 2020 data: LU: Publications Office; 2022. Available from: (accessed 7 Jul 2022).
Iacchini S, Pezzotti P, Caramia A, Del Grosso M, Camilli R, Errico G, et al. AR-ISS: sorveglianza nazionale dell’Antibiotico-Resistenza. Dati 2021. Roma: Istituto Superiore di Sanità; 2022. Available from:
Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516.
European Centre for Disease Prevention and Control. ECDC country visit to Italy to discuss antimicrobial resistance issues: 9 13 January 2017: LU: Publications Office; 2017. Available from: (accessed 7 Jul 2022).
World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. Available from: (accessed 25 Jan 2023).
A European one health action plan against antimicrobial resistance (AMR); 2020. Available from: (accessed 2 Jan 2023).
Piano Nazionale di Contrasto dell’Antimicrobico-Resistenza. PNCAR 2017-2020. Available from: (accessed 2 Jan 2023).
Piano_Nazionale_di_Contrasto_allAntibiotico_resistenza_2022_-_2025.pdf. Available from: (accessed 27 Jan 2023).
Pulcini C, Binda F, Lamkang AS, Trett A, Charani E, Goff DA, et al. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect. 2019;25(1):20–5.
Fabbro E, Arnau Sánchez J, Del Pilar López Acuña M, Hukelová H, Alcaraz Quiñonero M, Pantosti A, et al. Where we are in the fight against antimicrobial resistance and healthcare-associated infections. The opinion of the stakeholders of the European Joint action on antimicrobial resistance and healthcare-associated infections (EU-JAMRAI). Ann Ist Super Sanita. 2022;58(3):204–12.
Giardina S, Castiglioni S, Corno G, Fanelli R, Maggi C, Migliore L, et al. Approccio ambientale all’antimicrobico-resistenza. Roma; 2021. Available from:
Mader R, Muñoz Madero C, Aasmäe B, Bourély C, Broens EM, Busani L, et al. Review and analysis of national monitoring systems for antimicrobial resistance in animal bacterial pathogens in Europe: a basis for the development of the European antimicrobial resistance surveillance network in veterinary medicine (EARS-Vet). Front Microbiol. 2022;13:838490.
Mader R, Damborg P, Amat J-P, Bengtsson B, Bourély C, Broens EM, et al. Building the European antimicrobial resistance surveillance network in veterinary medicine (EARS-Vet). Eurosurveillance. 2021;26(4):2001359.
Lacotte Y, Årdal C, Ploy M-C; European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections EU-JAMRAI. Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis. Antimicrob Resist Infect Control. 2020;9(1):142.
Peñalva G, Crespo-Robledo P, Molvik M, López-Navas, A, Kacelnik, O, Cisneros, JM, et al. A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020. Eurosurveillance. 2022;27(46):2200082.
EU-JAMRAI LAYMAN REPORT pdf. Available from: (accessed 2 Jan 2023).
You do not currently have access to this content.